eXoZymes Inc (EXOZ)

Healthcare | Biotechnology
Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$0.0

Net Income

-$2.4M

Operating Margin

N/A

Free Cash Flow

-$8.9M

Debt / Assets

20.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for eXoZymes Inc (EXOZ).
Income Statement (Quarterly) 2026-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,255,661 2,706,026 888,239 1,091,209
Operating Expenses 2,376,669 3,966,632 1,611,726 1,328,604
Operating Income 0 -3,966,632 -1,611,726 -1,328,604
Interest Expense 13,716 0 0 0
Income Before Tax -2,370,247 -3,676,234 -1,656,373 -1,358,386
Income Tax Expense 0 -4,286 0 2,144
Net Income -2,370,247 -3,671,948 -1,656,373 -1,360,530
Per Share
EPS -0.28 0.00 -0.20 0.00
EPS Diluted 0.00 0.00 0.00 0.00